Mounjaro vs Zepbound: What Is the Difference?
Last updated: January 2026
Quick Answer
Both contain tirzepatide. Mounjaro is approved for diabetes, Zepbound for weight loss. Same medication, different FDA indications and insurance coverage.
Mounjaro vs Zepbound: What Is the Difference
Both contain tirzepatide. Mounjaro is approved for diabetes, Zepbound for weight loss. Same medication, different FDA indications and insurance coverage.
Understanding how GLP-1 medications work, their differences, and what to expect during treatment helps you make informed decisions about your weight loss journey. These medications represent a breakthrough in obesity treatment, with clinical trial results that far exceed previous weight loss interventions.
Key Facts
- GLP-1 medications are FDA-approved and backed by large-scale clinical trials
- Semaglutide and tirzepatide are the two most commonly prescribed GLP-1 medications for weight loss
- Both are administered as weekly subcutaneous injections using easy-to-use pen devices
- Treatment starts at a low dose and gradually increases over 16-20 weeks
- Most patients experience significant appetite reduction within the first week
Choosing the Right Medication
Your healthcare provider will help determine which GLP-1 medication is best for your specific situation based on your health conditions, weight loss goals, insurance coverage, and budget. Both semaglutide and tirzepatide are highly effective options.
Learn more about this medication: Tirzepatide Complete Guide
Related Questions
Semaglutide vs Tirzepatide: Which Is Better?
Tirzepatide shows higher average weight loss (20-22% vs 15%) by targeting two receptors. Semaglutide has more long-term safety data and lower starting cost.
Is Mounjaro or Zepbound Cheaper?
Both contain tirzepatide and cost about $1,100/mo. Insurance coverage may differ based on your diagnosis — diabetes vs weight management.